Department of Obstetrics & Gynaecology, National University Hospital, Singapore, Singapore.
Eur J Contracept Reprod Health Care. 2024 Apr;29(2):53-60. doi: 10.1080/13625187.2023.2300944. Epub 2024 Jan 29.
In addition to its widely-appreciated contraceptive applications, the oral contraceptive pill (OCP) conveys both oncological and non-oncological benefits. Oncological benefits include a decreased risk of endometrial, ovarian, and colorectal cancer. Non-oncological benefits include reducing androgenic effects and alleviating menstruation-related problems. This study aimed to ascertain knowledge levels of non-contraceptive benefits and risks of OCP use among participants without contraindications to OCPs. This study also assessed factors associated with participants being more likely to consider taking OCPs.
263 women aged 21 to 40 years old with no contraindications for OCP usage participated in this study. An anonymous questionnaire collected sociodemographic information and assessed participants' knowledge of the non-contraceptive benefits and risks associated with OCP use. Multivariate linear regression was used to assess factors associated with knowledge levels. Multivariate logistic regression was used to investigate factors associated with being more likely to consider taking OCPs among women who did not presently take them.
Multivariate logistic regression revealed that participants who were more knowledgeable overall about the non-contraceptive benefits of OCPs were more likely to consider taking OCPs (coefficient = 0.184, -value = 0.00). Knowledge of both oncological and non-oncological benefits of OCP use was relatively poor, especially among older women. Current OCP users were found to be more knowledgeable about their benefits.
As women with greater knowledge of non-contraceptive benefits of OCPs are more likely to consider taking them, knowledge gaps regarding OCPs should be filled, so that more women may reap the non-contraceptive benefits of OCPs.
除了广泛认可的避孕应用外，口服避孕药（OCP）还具有肿瘤学和非肿瘤学益处。肿瘤学益处包括降低子宫内膜癌、卵巢癌和结直肠癌的风险。非肿瘤学益处包括减少雄激素作用和缓解与月经相关的问题。本研究旨在确定无 OCP 使用禁忌证的参与者对 OCP 非避孕益处和风险的知识水平。本研究还评估了与参与者更有可能考虑使用 OCP 相关的因素。
本研究纳入了 263 名年龄在 21 至 40 岁之间、无 OCP 使用禁忌证的女性。一份匿名问卷收集了社会人口统计学信息，并评估了参与者对 OCP 使用相关非避孕益处和风险的了解程度。多变量线性回归用于评估与知识水平相关的因素。多变量逻辑回归用于调查在目前未服用 OCP 的女性中，与更有可能考虑服用 OCP 相关的因素。
多变量逻辑回归显示，对 OCP 非避孕益处总体了解更多的参与者更有可能考虑服用 OCP（系数=0.184，P 值=0.00）。对 OCP 使用的肿瘤学和非肿瘤学益处的了解相对较差，尤其是在年龄较大的女性中。当前使用 OCP 的女性对其益处的了解更为丰富。
由于对 OCP 非避孕益处了解更多的女性更有可能考虑使用它们，因此应该填补 OCP 方面的知识空白，以便更多的女性可以受益于 OCP 的非避孕益处。
